We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Allogeneic stem cell transplantation (AlloSCT) is the only potentially curative therapy for chronic lymphocytic leukemia (CLL), but high transplant-related morbidity and mortality rates limit its widespread use. Data on the long-term toxicity of alloSCT in this group of patients are lacking. We evaluated response and survival rates as well as measures of(More)
  • 1